Atossa Therapeutics, Inc. Liquidation Value
ATOS
Other
Cash & Equivalents
$41.30M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $41.30M
Total Obligations: -$8.26M
$33.04M
Per share: $3.84
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $41.30M
AR: $0
Total Obligations: -$8.26M
$33.04M
Per share: $3.84
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $41.30M
AR: $0
Inventory: $0
Total Obligations: -$8.26M
$33.04M
Per share: $3.84
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $33.04M | $3.84 |
| Liquid Liquidation Value | $33.04M | $3.84 |
| Operating Liquidation Value | $33.04M | $3.84 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $41.30M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $8.26M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 8.6M |
Explore all 127 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $41.30M | N/A | N/A | $4.29M | $8.26M | N/A | N/A | N/A |
| 2025-09-30 | $51.84M | N/A | N/A | $3.54M | $8.22M | N/A | N/A | N/A |
| 2025-06-30 | $57.86M | N/A | N/A | $2.01M | $6.82M | N/A | N/A | N/A |
| 2025-03-31 | $65.12M | N/A | N/A | $1.17M | $5.42M | N/A | N/A | N/A |
▼ Community Notes